Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
the Laboratory of Nano Particles at Empa and also matriculate in ETH Zürich. The research focuses on developing innovative plasmonic materials. Surface plasmon resonance (SPR) and localized surface
-
% of the cases occur in developing countries, and most of these cases would be preventable with appropriate treatment. We are therefore developing an optically transparent, engineered corneal transplant
-
. Empa is a research institution of the ETH Domain. The Coating Technologies Group in Empa's Laboratory for Surface Science & Coating Technologies develops next-generation functional thin-films through
-
with our team of experienced scientists, postdocs and PhD students, you will develop materials that contribute to the development of the next generation of sustainable biocomposite materials. This project is
-
healing. Developing innovative implants that can better integrate with the body, reduce complications, and improve patient outcomes is essential in addressing this urgent healthcare challenge. Though rooted
-
. Together with our team of experienced scientists, postdocs and PhD students, you will develop materials that contribute to the development of the next generation of bio-based hybrid materials. The goal
-
. Together with our team of experienced scientists, postdocs and PhD students, you will develop materials that contribute to the development of the next generation of advanced hydrogels for wound care
-
. Empa is a research institution of the ETH Domain. Our Structural Engineering Research Laboratory developed new materials, systems, and manufacturing techniques for civil infrastructure use. It is one
-
. Empa is a research institution of the ETH Domain. Our group focusses on the development of carbon-based (thermo)electric nanoscale devices and their application for quantum technologies and energy
-
work in close collaboration researchers and clinical experts from the University of Bern. Your contribution: Application and further development of 3D virtual histopathology by X-ray phase contrast micro